Lupin Expands U.S. Portfolio With FDA-Approved Sugammadex
MUMBAI, India and NAPLES, Fla., July 31, 2026 Lupin Limited has received approval from the U.S. Food and Drug...
injectable medicines
Advertisement
Lupin Boosts U.S. Generics Business with FDA Approval
MUMBAI, India, and NAPLES, Fla., July 28, 2026 Lupin Limited has received U.S. Food and Drug Administration (FDA) approval...
Amneal Wins FDA Approval for Expanded Iohexol Portfolio
Bridgewater, N.J., July 17, 2026 Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved additional...
Lilly Expands U.S. Injectable Manufacturing With $3.5B Site
INDIANAPOLIS / LEHIGH VALLEY, Pa., Jan. 30, 2026 — Eli Lilly announced plans to invest more than $3.5 billion...
Apiject Submits First-of-Its-Kind Prefilled Injection Device for FDA Review
STAMFORD, CT, September 25, 2025 — Apiject Systems, Corp., a leading medical technology innovator, submitted its New Drug Application...
Advertisement
